Concourse Financial Group Securities’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,000
| Closed | -$2.31K | – | 5783 |
|
|
2024
Q4 | $2.31K | Hold |
1,000
| – | – | ﹤0.01% | 1996 |
|
|
2024
Q3 | $2.44K | Hold |
1,000
| – | – | ﹤0.01% | 1969 |
|
|
2024
Q2 | $2.57K | Hold |
1,000
| – | – | ﹤0.01% | 1996 |
|
|
2024
Q1 | $2.92K | Hold |
1,000
| – | – | ﹤0.01% | 1992 |
|
|
2023
Q4 | $2.31K | Hold |
1,000
| – | – | ﹤0.01% | 1995 |
|
|
2023
Q3 | $2.61K | Hold |
1,000
| – | – | ﹤0.01% | 1951 |
|
|
2023
Q2 | $3.58K | Hold |
1,000
| – | – | ﹤0.01% | 1905 |
|
|
2023
Q1 | $2.18K | Hold |
1,000
| – | – | ﹤0.01% | 2041 |
|
|
2022
Q4 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 1596 |
|
|
2022
Q3 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 1612 |
|
|
2022
Q2 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 1844 |
|
|
2022
Q1 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 1718 |
|
|
2021
Q4 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 1764 |
|
|
2021
Q3 | $22K | Buy |
+1,000
| New | +$22K | ﹤0.01% | 1629 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5314 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5159 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5026 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4827 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4690 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4670 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4608 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4415 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4584 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4519 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4394 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4128 |
|